Registry analysis finds similar outcomes for TAVR devices

An analysis of the PRAGMATIC registry of transcatheter aortic valve replacement cases found little difference in outcomes between the Sapien/Sapien XT and CoreValve devices except that permanent pacemakers were more often needed with the CoreValve device, according to findings published in the Journal of the American College of Cardiology. The analysis assessed 30-day and one-year outcomes for the devices in 793 patients. SCAI President Dr. J. Jeffrey Marshall said clinicians are likely aware of the pacemaker issue, but he said it does not occur in many patients. "The need for a permanent pacemaker implantation is not something that's associated with a lot of complications in and of itself, so it's not that great an issue, although there is an extra cost, obviously," Marshall said.

View Full Article in:

TheHeart.org (Montreal) (free registration) · CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC